Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Factors associated with willingness to provide biospecimens for genetics research among African American cancer survivors.

Ewing AT, Kalu N, Cain G, Erby LH, Ricks-Santi LJ, Tetteyfio-Kidd Telemaque E, Scott DM.

J Community Genet. 2019 Mar 14. doi: 10.1007/s12687-019-00411-0. [Epub ahead of print]

PMID:
30877487
2.

Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma.

Dengler HS, Wu X, Peng I, Rinderknecht CH, Kwon Y, Suto E, Kohli PB, Liimatta M, Barrett K, Lloyd J, Cain G, Briggs M, Addo S, Salmon G, Ubhayakar S, Deshmukh G, Shahidi-Latham SK, Quiason-Huynh CM, Jackman J, Liu J, Ray NC, Goodacre SC, Johnson A, McKenzie BS, Lee WP, Zak M, Kenny JR, Ghilardi N.

Sci Transl Med. 2018 Nov 21;10(468). pii: eaao2151. doi: 10.1126/scitranslmed.aao2151.

PMID:
30463918
3.

Improving Access to Care by Admission Process Redesign in a Veterans Affairs Skilled Nursing Facility.

Baughman AW, Cain G, Ruopp MD, Concepcion C, Oliveira C, O'Toole R, Saunders S, Jindal SK, Ferreira M, Simon SR.

Jt Comm J Qual Patient Saf. 2018 Aug;44(8):454-462. doi: 10.1016/j.jcjq.2018.04.002. Epub 2018 May 29.

4.

Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.

Jarzabek MA, Proctor WR, Vogt J, Desai R, Dicker P, Cain G, Raja R, Brodbeck J, Stevens D, van der Stok EP, Martens JWM, Verhoef C, Hegde PS, Byrne AT, Tarrant JM.

PLoS One. 2018 Jun 7;13(6):e0198099. doi: 10.1371/journal.pone.0198099. eCollection 2018.

5.

Proof of Concept for an Automated Image Analysis Method to Quantify Rat Bone Marrow Hematopoietic Lineages on H&E Sections.

Kozlowski C, Fullerton A, Cain G, Katavolos P, Bravo J, Tarrant JM.

Toxicol Pathol. 2018 Apr;46(3):336-347. doi: 10.1177/0192623318766458.

PMID:
29683092
6.

An Automated Image Analysis Method to Quantify Veterinary Bone Marrow Cellularity on H&E Sections.

Kozlowski C, Brumm J, Cain G.

Toxicol Pathol. 2018 Apr;46(3):324-335. doi: 10.1177/0192623318766457.

PMID:
29683091
7.

MEK and ERK Kinase Inhibitors Increase Circulating Ceruloplasmin and Cause Green Serum in Rats.

Diaz D, Pai R, Cain G, La N, Dambach D, Schwartz J, Tarrant JM.

Toxicol Pathol. 2017 Feb;45(2):353-361. doi: 10.1177/0192623316664590. Epub 2016 Sep 28.

PMID:
27565173
8.

Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates.

Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer GF, Habermann G, Xiao J, Woods C, Grogan J, Gelzleichter T, Cain G.

Reprod Toxicol. 2016 Aug;63:82-95. doi: 10.1016/j.reprotox.2016.05.014. Epub 2016 May 20.

PMID:
27211603
9.

Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window.

Rudolph J, Murray LJ, Ndubaku CO, O'Brien T, Blackwood E, Wang W, Aliagas I, Gazzard L, Crawford JJ, Drobnick J, Lee W, Zhao X, Hoeflich KP, Favor DA, Dong P, Zhang H, Heise CE, Oh A, Ong CC, La H, Chakravarty P, Chan C, Jakubiak D, Epler J, Ramaswamy S, Vega R, Cain G, Diaz D, Zhong Y.

J Med Chem. 2016 Jun 9;59(11):5520-41. doi: 10.1021/acs.jmedchem.6b00638. Epub 2016 May 24.

PMID:
27167326
10.

PANACEA OR PLACEBO? AN EVALUATION OF THE VALUE OF EMOTIONAL INTELLIGENCE IN HEALTHCARE WORKERS.

Vandewaa EA, Turnipseed DL, Cain G.

J Health Hum Serv Adm. 2016 Spring;38(4):438-77.

PMID:
27079056
11.

Beliefs and Preferences for Medical Research Among African-Americans.

Cain GE, Kalu N, Kwagyan J, Marshall VJ, Ewing AT, Bland WP, Hesselbrock V, Taylor RE, Scott DM.

J Racial Ethn Health Disparities. 2016 Mar;3(1):74-82. doi: 10.1007/s40615-015-0117-8. Epub 2015 May 16.

12.

Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation.

Couch JA, Zhang G, Beyer JC, de Zafra CL, Gupta P, Kamath AV, Lewin-Koh N, Tarrant J, Allamneni KP, Cain G, Yee S, Ross S, Cook R, Tsai SP, Ruppel J, Ridgway JB, Paluch M, Hass PE, Franklin J, Yan M.

Clin Cancer Res. 2016 Mar 15;22(6):1469-79. doi: 10.1158/1078-0432.CCR-15-1380. Epub 2015 Nov 20.

13.

Impact of a multicomponent screening, brief intervention, and referral to treatment (SBIRT) training curriculum on a medical residency program.

Kalu N, Cain G, McLaurin-Jones T, Scott D, Kwagyan J, Fassassi C, Greene W, Taylor RE.

Subst Abus. 2016;37(1):242-7. doi: 10.1080/08897077.2015.1035841. Epub 2015 May 11.

14.

Genetic testing for the susceptibility to alcohol dependence: interest and concerns in an African American population.

Scott DM, Nwulia E, Kwagyan J, Cain G, Marshall VJ, Kalu N, Ewing A, Taylor RE.

Genet Test Mol Biomarkers. 2014 Aug;18(8):538-45. doi: 10.1089/gtmb.2013.0417. Epub 2014 Jun 13.

15.

Eczema herpeticum in a wrestler.

Shenoy R, Mostow E, Cain G.

Clin J Sport Med. 2015 Jan;25(1):e18-9. doi: 10.1097/JSM.0000000000000097.

PMID:
24714395
16.

Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900.

Blackwood E, Epler J, Yen I, Flagella M, O'Brien T, Evangelista M, Schmidt S, Xiao Y, Choi J, Kowanetz K, Ramiscal J, Wong K, Jakubiak D, Yee S, Cain G, Gazzard L, Williams K, Halladay J, Jackson PK, Malek S.

Mol Cancer Ther. 2013 Oct;12(10):1968-80. doi: 10.1158/1535-7163.MCT-12-1218. Epub 2013 Jul 19.

17.

Alcohol dependence and health care utilization in African Americans.

Marshall VJ, Kalu N, Kwagyan J, Scott DM, Cain GE, Hill K, Hesselbrock V, Ferguson CL, Taylor RE.

J Natl Med Assoc. 2013 Spring;105(1):42-9.

18.

Skin infections in athletes: treating the patient, protecting the team.

Shah N, Cain G, Naji O, Goff J.

J Fam Pract. 2013 Jun;62(6):284-91. No abstract available.

PMID:
23828800
19.

Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG.

Wang X, Quarmby V, Ng C, Chuntharapai A, Shek T, Eigenbrot C, Kelley RF, Shia S, McCutcheon K, Lowe J, Leddy C, Coachman K, Cain G, Chu F, Hotzel I, Maia M, Wakshull E, Yang J.

MAbs. 2013 Jul-Aug;5(4):540-54. doi: 10.4161/mabs.24822. Epub 2013 Apr 29.

20.

Pharmacokinetic drivers of toxicity for basic molecules: strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor.

Diaz D, Ford KA, Hartley DP, Harstad EB, Cain GR, Achilles-Poon K, Nguyen T, Peng J, Zheng Z, Merchant M, Sutherlin DP, Gaudino JJ, Kaus R, Lewin-Koh SC, Choo EF, Liederer BM, Dambach DM.

Toxicol Appl Pharmacol. 2013 Jan 1;266(1):86-94. doi: 10.1016/j.taap.2012.10.026. Epub 2012 Nov 7.

PMID:
23142475
21.

Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology.

Erickson RI, Tarrant J, Cain G, Lewin-Koh SC, Dybdal N, Wong H, Blackwood E, West K, Steigerwalt R, Mamounas M, Flygare JA, Amemiya K, Dambach D, Fairbrother WJ, Diaz D.

Toxicol Sci. 2013 Jan;131(1):247-58. doi: 10.1093/toxsci/kfs265. Epub 2012 Sep 5.

PMID:
22956632
22.

Institutional incorporation of screening, brief intervention, and referral to treatment (SBIRT) in residency training: achieving a sustainable curriculum.

Scott DM, McLaurin-Jones T, Brown FD, Newton R, Marshall VJ, Kalu N, Cain GE, Taylor RE.

Subst Abus. 2012;33(3):308-11. doi: 10.1080/08897077.2011.640135.

PMID:
22738011
23.

Screening, brief intervention, and referral to treatment: public health training for primary care.

Marshall VJ, McLaurin-Jones TL, Kalu N, Kwagyan J, Scott DM, Cain G, Greene W, Adenuga B, Taylor RE.

Am J Public Health. 2012 Aug;102(8):e30-6. doi: 10.2105/AJPH.2012.300802. Epub 2012 Jun 14.

24.

Heritability of level of response and association with recent drinking history in nonalcohol-dependent drinkers.

Kalu N, Ramchandani VA, Marshall V, Scott D, Ferguson C, Cain G, Taylor R.

Alcohol Clin Exp Res. 2012 Jun;36(6):1034-41. doi: 10.1111/j.1530-0277.2011.01699.x. Epub 2012 Jan 11.

25.

Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model.

Pastuskovas CV, Mundo EE, Williams SP, Nayak TK, Ho J, Ulufatu S, Clark S, Ross S, Cheng E, Parsons-Reponte K, Cain G, Van Hoy M, Majidy N, Bheddah S, dela Cruz Chuh J, Kozak KR, Lewin-Koh N, Nauka P, Bumbaca D, Sliwkowski M, Tibbitts J, Theil FP, Fielder PJ, Khawli LA, Boswell CA.

Mol Cancer Ther. 2012 Mar;11(3):752-62. doi: 10.1158/1535-7163.MCT-11-0742-T. Epub 2012 Jan 5.

26.

Preclinical stereoselective disposition and toxicokinetics of two novel MET inhibitors.

Liederer BM, Liu X, Berezhkovskiy LM, Cain G, Ding X, Gaudino J, Kaus R, Plise EG, Sutherlin DP, Harstad EB.

Xenobiotica. 2012 May;42(5):456-65. doi: 10.3109/00498254.2011.632697. Epub 2011 Nov 28.

PMID:
22122353
27.

Phosphorous dysregulation induced by MEK small molecule inhibitors in the rat involves blockade of FGF-23 signaling in the kidney.

Diaz D, Allamneni K, Tarrant JM, Lewin-Koh SC, Pai R, Dhawan P, Cain GR, Kozlowski C, Hiraragi H, La N, Hartley DP, Ding X, Dean BJ, Bheddah S, Dambach DM.

Toxicol Sci. 2012 Jan;125(1):187-95. doi: 10.1093/toxsci/kfr263. Epub 2011 Oct 5.

PMID:
21976371
28.

Presidential address. Sanitizing sewage sludge: the intersection of parasitology, civil engineering, and public health.

Cain GD.

J Parasitol. 2010 Dec;96(6):1037-40. doi: 10.1645/GE-2631.1. Epub 2010 Aug 23. No abstract available.

PMID:
21158605
29.

Metam sodium reduces viability and infectivity of Eimeria oocysts.

Fetterer RH, Jenkins MC, Miska KB, Cain GD.

J Parasitol. 2010 Jun;96(3):632-7. doi: 10.1645/GE-2345.1.

PMID:
20557209
30.

Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

Schnegelsberg B, Sun TT, Cain G, Bhattacharya A, Nunn PA, Ford AP, Vizzard MA, Cockayne DA.

Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R534-47. doi: 10.1152/ajpregu.00367.2009. Epub 2009 Dec 23. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1447.

31.

Clinical course of alcohol dependence in African Americans.

Scott DM, Williams CD, Cain GE, Kwagyan J, Kalu N, Ehlers CL, Hesselbrock V, Taylor RE.

J Addict Dis. 2008;27(4):43-50. doi: 10.1080/10550880802324754.

PMID:
19042590
32.

Surveillance for early silicosis in high altitude miners using pulse oximetry.

Donroe JA, Maurtua-Neumann PJ, Gilman RH, Acosta AT, Cain G, Parker JE, Carhuaricra JC, Padilla JJ, Mendoza D, Zimic M, Moore DA.

Int J Occup Environ Health. 2008 Jul-Sep;14(3):187-92.

PMID:
18686718
33.

Attitudes toward medical and mental health care delivered via telehealth applications among rural and urban primary care patients.

Grubaugh AL, Cain GD, Elhai JD, Patrick SL, Frueh BC.

J Nerv Ment Dis. 2008 Feb;196(2):166-70. doi: 10.1097/NMD.0b013e318162aa2d.

PMID:
18277227
34.

Age differences in posttraumatic stress disorder, psychiatric disorders, and healthcare service use among veterans in Veterans Affairs primary care clinics.

Frueh BC, Grubaugh AL, Acierno R, Elhai JD, Cain G, Magruder KM.

Am J Geriatr Psychiatry. 2007 Aug;15(8):660-72.

PMID:
17670996
36.

Vascular endothelial growth factor and platelets in primary (essential) thrombocythaemia.

Blann A, Cain G, Bareford D.

Br J Haematol. 2006 Feb;132(4):530-1. No abstract available.

PMID:
16412026
37.

Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunit.

Bhattacharya A, Dang H, Zhu QM, Schnegelsberg B, Rozengurt N, Cain G, Prantil R, Vorp DA, Guy N, Julius D, Ford AP, Lester HA, Cockayne DA.

J Neurosci. 2004 Jun 16;24(24):5537-48.

38.

Tobacco smoke exposure, wheeze, and atopy.

Murray CS, Woodcock A, Smillie FI, Cain G, Kissen P, Custovic A; NACMAAS Study Group.

Pediatr Pulmonol. 2004 Jun;37(6):492-8.

PMID:
15114549
39.

Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands.

Arvanitis AG, Rescinito JT, Arnold CR, Wilde RG, Cain GA, Sun JH, Yan JS, Teleha CA, Fitzgerald LW, McElroy J, Zaczek R, Hartig PR, Grossman S, Arneric SP, Gilligan PJ, Olson RE, Robertson DW.

Bioorg Med Chem Lett. 2003 Jan 6;13(1):125-8.

PMID:
12467631
40.

Household characteristics and mite allergen levels in Manchester,UK.

Simpson A, Simpson B, Custovic A, Cain G, Craven M, Woodcock A.

Clin Exp Allergy. 2002 Oct;32(10):1413-9.

PMID:
12372118
41.

A common oocyst surface antigen of Cryptosporidium recognized by monoclonal antibodies.

Yu JR, O'Hara SP, Lin JL, Dailey ME, Cain G, Lin JL.

Parasitol Res. 2002 May;88(5):412-20.

PMID:
12049457
42.

Lymphoproliferative responses in cord blood and at one year: no evidence for the effect of in utero exposure to dust mite allergens.

Smillie FI, Elderfield AJ, Patel F, Cain G, Tavenier G, Brutsche M, Craven M, Custovic A, Woodcock A.

Clin Exp Allergy. 2001 Aug;31(8):1194-204.

PMID:
11529888
43.

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice.

Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP.

Nature. 2000 Oct 26;407(6807):1011-5.

PMID:
11069181
44.

Detrusor myopathy in young beagle dogs.

Cain GR, Tsai K, Pulley LT, Taylor M.

Toxicol Pathol. 2000 Jul-Aug;28(4):565-7.

PMID:
10930043
45.

Measuring outcomes in outpatient settings. How one company is using clinical pathways for depression.

Dykes PC, Cain G.

Behav Healthc Tomorrow. 1999 Dec;8(6):23-6. No abstract available.

PMID:
10747579
46.

Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3).

Batt DG, Petraitis JJ, Houghton GC, Modi DP, Cain GA, Corjay MH, Mousa SA, Bouchard PJ, Forsythe MS, Harlow PP, Barbera FA, Spitz SM, Wexler RR, Jadhav PK.

J Med Chem. 2000 Jan 13;43(1):41-58.

PMID:
10633037
47.

The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.

Irving JA, Cain G, Howard M, Angus B, Taylor PR, Cattan AR.

J Clin Pathol. 1998 Oct;51(10):776-80.

48.

The effect of dry heat on mite, cat, and dog allergens.

Cain G, Elderfield AJ, Green R, Smillie FI, Chapman MD, Custovic A, Woodcock A.

Allergy. 1998 Dec;53(12):1213-5.

PMID:
9930600
49.
50.

Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists.

Xue CB, Wityak J, Sielecki TM, Pinto DJ, Batt DG, Cain GA, Sworin M, Rockwell AL, Roderick JJ, Wang S, Orwat MJ, Frietze WE, Bostrom LL, Liu J, Higley CA, Rankin FW, Tobin AE, Emmett G, Lalka GK, Sze JY, Di Meo SV, Mousa SA, Thoolen MJ, Racanelli AL, Olson RE, et al.

J Med Chem. 1997 Jun 20;40(13):2064-84.

PMID:
9207948

Supplemental Content

Support Center